Roles of collateral arterial flow and ischemic preconditioning in protection of acutely ischemic myocardium

2014 ◽  
Vol 47 (4) ◽  
pp. 491-499 ◽  
Author(s):  
Robert B. Jennings ◽  
Galen S. Wagner
HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S501-S502
Author(s):  
S.H.S. Reddy ◽  
D. Jain ◽  
N.R. Dash

2011 ◽  
Vol 77 (5) ◽  
pp. 608-611 ◽  
Author(s):  
Amy B. Christie ◽  
D. Benjamin Christie ◽  
Don K. Nakayama ◽  
Maurice M. Solis

With the development of endovascular therapy, treatment for hepatic artery aneurysm (HAA) has evolved from open excision and repair to include endovascular approaches. We reviewed our recent experience with HAA to help define the treatment of HAA. From 2002 to 2010, five patients underwent treatment of HAA, all men with a median age of 63.2 years (range, 41-75). The median diameter of HAA was 5.8 cm (range, 2.4 cm-11 cm). Four lesions involved the extrahepatic portion of the hepatic artery, and one was an intrahepatic HAA that involved the right hepatic artery. Three were true aneurysms and two were pseudoaneurysms associated with trauma. Four of the five HAA patients were symptomatic, three with nonspecific abdominal pain, and one with free hemorrhage from a ruptured intrahepatic pseudoaneurysm. All five underwent computed tomography and selective arteriography. Two patients underwent open surgical aneurysmectomy and revascularization because of aneurysm location and concerns of the potential lack of collateral flow. Three patients underwent an endovascular coil embolization because obliteration of a saccular aneurysm could be achieved without compromising arterial flow of the native hepatic vessel. Re-embolization was necessary in the intrahepatic aneurysm because of recanalization of a feeding vessel. Endovascular embolization is an important minimally invasive approach in the treatment of HAA. Depending on HAA location and the adequacy of collateral arterial flow around the lesion, open aneurysmectomy and revascularization may be required.


1986 ◽  
Vol 64 (4) ◽  
pp. 527-527 ◽  
Author(s):  
GREGORY S. NOWAK ◽  
S. S. MOORTHY ◽  
WILLIAM L. MCNIECE

2013 ◽  
Vol 304 (11) ◽  
pp. H1407-H1414 ◽  
Author(s):  
Nis Stride ◽  
Steen Larsen ◽  
Martin Hey-Mogensen ◽  
Christina N. Hansen ◽  
Clara Prats ◽  
...  

Chronic ischemic heart disease is associated with myocardial hypoperfusion. The resulting hypoxia potentially inflicts damage upon the mitochondria, leading to a compromised energetic state. Furthermore, ischemic damage may cause excessive production of reactive oxygen species (ROS), producing mitochondrial damage, hereby reinforcing a vicious circle. Ischemic preconditioning has been proven protective in acute ischemia, but the subject of chronic ischemic preconditioning has not been explored in humans. We hypothesized that mitochondrial respiratory capacity would be diminished in chronic ischemic regions of human myocardium but that these mitochondria would be more resistant to ex vivo ischemia and, second, that ROS generation would be higher in ischemic myocardium. The aim of this study was to test mitochondrial respiratory capacity during hyperoxia and hypoxia, to investigate ROS production, and finally to assess myocardial antioxidant levels. Mitochondrial respiration in biopsies from ischemic and nonischemic regions from the left ventricle of the same heart was compared in nine human subjects. Maximal oxidative phosphorylation capacity in fresh muscle fibers was lower in ischemic compared with nonischemic myocardium ( P < 0.05), but the degree of coupling (respiratory control ratio) did not differ ( P > 0.05). The presence of ex vivo hypoxia did not reveal any chronic ischemic preconditioning of the ischemic myocardial regions ( P > 0.05). ROS production was higher in ischemic myocardium ( P < 0.05), and the levels of antioxidant protein expression was lower. Diminished mitochondrial respiration capacity and excessive ROS production demonstrate an impaired mitochondrial function in ischemic human heart muscle. No chronic ischemic preconditioning effect was found.


2001 ◽  
Vol 33 (11) ◽  
pp. 1989-2005 ◽  
Author(s):  
Yasuchika Takeishi ◽  
Qunhua Huang ◽  
Tingchung Wang ◽  
Michael Glassman ◽  
Masanori Yoshizumi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document